As the increased 20S proteasome activity in Onc-p53 NSCLC cells might signal enhanced sensitivity to PIs, we explored PI cytotoxicity in Onc-p53 versus WT p53 NSCLC cells. The gene discussed is TP53; the disease is non-small cell lung carcinoma.